SAMSARA BIOCAPITAL
Samsara Biocapital, LLC provides investment advisory services.
SAMSARA BIOCAPITAL
Industry:
Financial Services
Founded:
2016-09-23
Status:
Active
Contact:
1-650-285-4270
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Cash App
Cash App is the fastest growing financial brand in the world.
Northpond Ventures
Northpond Ventures is a science-driven project capital firm that focuses on biotechnology and affiliated industries.
RA Capital Management
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Walden International
Walden International is a venture capital firm that specializes in a wide range of funding and investment for industries.
Current Employees Featured
Marcos Milla Venture Partner @ Samsara BioCapital
Venture Partner
Srinivas Akkaraju Founder & Managing Partner @ Samsara BioCapital
Founder & Managing Partner
2017-01-01
Mike Dybbs Partner @ Samsara BioCapital
Partner
2017-01-01
Stephen Shuttleworth Venture Partner @ Samsara BioCapital
Venture Partner
2019-01-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-08 | Autobahn Therapeutics | Samsara BioCapital investment in Venture Round - Autobahn Therapeutics | 32.7 M USD |
| 2022-07-18 | Delfi Diagnostics | Samsara BioCapital investment in Series B - Delfi Diagnostics | 225 M USD |
| 2022-06-29 | MiroBio | Samsara BioCapital investment in Series B - MiroBio | 80 M GBP |
| 2022-06-17 | Scholar Rock | Samsara BioCapital investment in Post-IPO Equity - Scholar Rock | 205 M USD |
| 2022-06-08 | Mineralys Therapeutics | Samsara BioCapital investment in Series B - Mineralys Therapeutics | 118 M USD |
| 2022-06-07 | ImmunOs Therapeutics | Samsara BioCapital investment in Series B - ImmunOs Therapeutics | 71 M CHF |
| 2022-06-02 | Upstream Bio | Samsara BioCapital investment in Series A - Upstream Bio | 200 M USD |
| 2022-04-08 | Lyra Therapeutics | Samsara BioCapital investment in Post-IPO Equity - Lyra Therapeutics | 100.5 M USD |
| 2022-02-22 | Eyebiotech | Samsara BioCapital investment in Series A - Eyebiotech | 65 M USD |
| 2022-02-09 | Seismic Therapeutic | Samsara BioCapital investment in Series A - Seismic Therapeutic | 101 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-03-05 | ElevateBio Appoints Kareem Reda as Chief Business Officer |
More informations about "Samsara BioCapital"
Samsara BioCapital - Crunchbase Investor Profile
Samsara Biocapital provides investment advisory services to help entrepreneurs turn their own ideas and visions into successful companies. Samsara BioCapital, as a results-driven organization, is always looking for ambitious and visionary …See details»
Team - Samsara Biocapital
Samsara Biocapital helping entrepreneurs turn their ideas into successful companies.See details»
Samsara BioCapital - Investments, Portfolio & Company Exits
Samsara BioCapital has made 39 diversity investments. Their most recent diversity investment was on Nov 18, 2024, when Aclaris Therapeutics raised. obfuscated. obfuscated. Announced …See details»
Portfolio Companies - Samsara Biocapital
IO Biotech (IOBT) is a clinical-stage biopharmaceutical company pioneering the discovery and development of novel and highly differentiated immune-oncology therapeutics based on its proprietary technology platform, T-win®, which …See details»
Samsara BioCapital investment portfolio - PitchBook
Samsara BioCapital's latest investment was on 18-Nov-2024 in Aclaris Therapeutics, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover …See details»
Samsara BioCapital: Fund Performance - PitchBook
Samsara BioCapital is a 2018 vintage venture capital fund managed by Samsara BioCapital. The fund is located in Palo Alto, California. The fund targets pharmaceuticals and biotechnology, …See details»
Samsara BioCapital - Funding, Financials, Valuation
Samsara BioCapital . Connect to CRM . Save . Summary. Financials. Investments. People. Technology. Signals & News. Similar Companies. Highlights. Funds 1. Funding. Samsara BioCapital has raised a total of …See details»
Samsara Biocapital, Evotec and KCK Launch Autobahn Labs, a …
Jun 24, 2020 Samsara BioCapital is a new breed of biotech investment fund focused on translating cutting-edge biology into new therapies to treat patients with unmet medical needs. …See details»
Our Culture - Samsara Biocapital
The culture at Samsara BioCapital is critical to our shared vision to have a significant impact on the lives of patients. We recognize that we accomplish this only indirectly, but we feel incredibly fortunate and grateful to have the …See details»
Samsara Biocapital 13F annual report (2024) - wallmine
$646 billion Assets Under Management (AUM) As of 8th May 2024, Samsara Biocapital’s top holding is 6,788,609 shares of Scholar Rock Hldg Corp currently worth over $121 billion and …See details»
SAMSARA BIOCAPITAL, LLC Top 13F Holdings - WhaleWisdom.com
Samsara Biocapital is a hedge fund with 3 clients and discretionary assets under management (AUM) of $1,622,845,390 (Form ADV from 2024-03-31). Their last reported 13F filing for Q3 …See details»
Srinivas Akkaraju - Founder & Managing Partner @ Samsara …
Jan 1, 2009 Akkaraju founded Samsara BioCapital in 2017, and has more than 18 years of investment and operational experience in the Life Sciences sector. Most recently, he was a …See details»
Neurogene Inc. sees significant stock purchases by Samsara …
5 days ago On November 26, Samsara BioCapital acquired a total of 48,770 shares of Neurogene's common stock, with transaction prices ranging from $24.91 to $27.50 per share. …See details»
Samsara BioCapital eyes $300M fund - PitchBook
Mar 24, 2017 Samsara BioCapital has set a target of $300 million for a new fund, per an SEC document. The regulatory filing lists Srinivas Akkaraju and Michael Dybbs as managing …See details»
Samsara adds three venture partners to help steer and advise …
Sep 24, 2024 Samsara BioCapital's new venture partners from L-R: Alan Eisenberg, Eric Dobmeier and John Orwin. September 24, 2024 10:00 AM EDT. People. Samsara adds three …See details»
Abe Bassan - Samsara Biocapital
Abe Bassan is a Principal at Samsara and joined the firm in 2017 when the fund was launched. He was previously Director of Program Biology at Revolution Medicines, where he co-led the …See details»
Samsara BioCapital Portfolio Companies - Crunchbase
Dec 8, 2014 Samsara Biocapital provides investment advisory services to help entrepreneurs turn their own ideas and visions into successful companies. This list of organizations invested …See details»
Samsara BioCapital - Private Equity List
Samsara BioCapital was founded after years of working in the medical field and investment industry. Our goal is to help entrepreneurs turn their own ideas and visions into successful …See details»
Samsara BioCapital - Contacts, Employees, Board Members
Samsara BioCapital has 5 current employee profiles, including Venture Partner Marcos Milla. Samsara BioCapital has 1 board member or advisor, John Curnutte. Contacts. Edit Contacts …See details»
Neurogene Inc. registra importantes compras de acciones por …
5 days ago El 26.11.2023, Samsara BioCapital adquirió un total de 48.770 acciones ordinarias de Neurogene, con precios de transacción que oscilaron entre 24,91 y 27,50 dólares por acción.See details»